Ballabeni, P

Brägger, CP; Ballabeni, P; Rogler, D; Vavricka, SR; Friedt, M; Pittet, Valérie; Swiss IBD Cohort Study Group, The (2011). Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age? Journal of pediatric gastroenterology and nutrition, 53(2), pp. 141-4. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MPG.0b013e318218be35

Pittet, V; Juillerat, P; Mottet, C; Felley, C; Ballabeni, P; Burnand, B; Michetti, P; Vader, JP; and, the Swiss IBD Cohort Study Group (2009). Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). International journal of epidemiology, 38(4), pp. 922-31. Oxford: Oxford University Press 10.1093/ije/dyn180

Laurencet, F; Ballabeni, P; Rufener, B; Hess, U; Cerny, T; Fey, M; Luthi, JM; Plancherel, C; Zulian, GB; Swiss, Group for Clinical Research (SAKK) (2007). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica, 117(1), pp. 40-7. Basel: Karger 10.1159/000096787

Weder, W; Stahel, RA; Bernhard, J; Bodis, S; Vogt, P; Ballabeni, P; Lardinois, D; Betticher, D; Schmid, R; Stupp, R; Ris, HB; Jermann, M; Mingrone, W; Roth, AD; Spiliopoulos, A; Swiss, Group for Clinical Cancer Research (2007). Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Annals of oncology, 18(7), pp. 1196-202. Oxford: Oxford University Press 10.1093/annonc/mdm093

Hess, D; Koberle, D; Thurlimann, B; Pagani, O; Schonenberger, A; Mattmann, S; Rochlitz, C; Rauch, D; Schuller, J C; Ballabeni, P; Ribi, K (2007). Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99). Onkologie, 73(3-4), pp. 228-37. Basel: Karger 10.1159/000180915